Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis

This study has been completed.
Sponsor:
Information provided by:
FDA Office of Orphan Products Development
ClinicalTrials.gov Identifier:
NCT00004414
First received: October 18, 1999
Last updated: March 24, 2015
Last verified: May 1999
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2002
  Estimated Primary Completion Date: No date given